MARC Record from marc_columbia

LEADER: 02251cam a2200469 a 4500
001 3923708
005 20221027002240.0
008 860210s1985 ne a b 101 0 eng d
010 $a 85001466
020 $a0444904085 (Elsevier)
035 $a(OCoLC)11622750
035 $a(OCoLC)ocm11622750
035 $a(CStRLIN)NYCM86-B411
035 $9ADH6278HS
035 $a(NNC)3923708
035 $a3923708
040 $aDNLM/DLC$cDLC$dCStRLIN
050 00 $aRC685.H8$bA37 1985
060 0 $aW1 CU786M no. 14$aWG 340 A2415 1984
082 0 $a616.1/32$219
245 00 $aAdrenergic blood pressure regulation :$bproceedings of a symposium, Corfu, 22-25 May 1984 /$ceditors, W.H. Birkenhäger, B. Folkow, H.A.J. Struyker Boudier.
260 $aAmsterdam ;$aPrinceton :$bExcerpta Medica ;$aNew York, N.Y., U.S.A. :$bSole distrubutors for the USA and Canada, Elsevier Science Pub. Co.,$c1985.
300 $aviii, 258 pages :$billustrations ;$c25 cm.
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
490 1 $aCurrent clinical practice series ;$vno. 14
504 $aIncludes bibliographies and index.
650 0 $aHypertension$xEtiology$vCongresses.
650 0 $aBlood pressure$xRegulation$vCongresses.
650 0 $aAdrenergic mechanisms$vCongresses.
650 0 $aHypertension$xChemotherapy$vCongresses.
650 0 $aAdrenergic beta blockers$vCongresses.
650 2 $aAdrenergic beta-Antagonists$xtherapeutic use.$0https://id.nlm.nih.gov/mesh/D000319Q000627
650 2 $aHypertension$xdrug therapy.$0https://id.nlm.nih.gov/mesh/D006973Q000188
650 2 $aSympathetic Nervous System$xdrug effects.$0https://id.nlm.nih.gov/mesh/D013564Q000187
650 2 $aSympathetic Nervous System$xphysiopathology.$0https://id.nlm.nih.gov/mesh/D013564Q000503
655 2 $aCongress.$0https://id.nlm.nih.gov/mesh/D016423
700 1 $aBirkenhäger, W. H.$0http://id.loc.gov/authorities/names/n81014092
700 1 $aFolkow, Björn.$0http://id.loc.gov/authorities/names/n84133746
700 1 $aStruyker-Boudier, H. A. J.$0http://id.loc.gov/authorities/names/n82256561
830 0 $aCurrent clinical practice series ;$v14.$0http://id.loc.gov/authorities/names/n83742000
852 00 $boff,hsl$hRC685.H8$iA37 1985